Validity of Viome's Oral/throat Cancer Test

Launched by VIOME · Dec 8, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a new test developed by Viome to help detect oral and throat cancers, specifically two types called oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC). The goal is to enroll at least 1,000 participants who have been suspected of having these types of cancer, with at least 107 participants being confirmed cases. Participants will provide saliva samples using special collection kits provided by Viome, and this will help researchers evaluate how well the test works.

To be eligible for the trial, participants must be adults aged 18 or older and have been identified by their doctor as possibly having OSCC or OPSCC. They need to be willing to follow the study instructions and sign a consent form before taking part in any study activities. However, pregnant individuals or those using fertility medications cannot participate. If you or someone you know is considering joining the trial, you can expect to contribute to important research that could improve how these types of cancer are detected in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed and dated informed consent prior to any study-specific procedures are performed
• • Willing and able to follow the study instructions, as described in the recruitment letter
• • Adults (18 years old or older)
• • Suspicion of OSCC or OPSCC on clinical presentation by a clinician
• Exclusion Criteria:
• • Pregnancy
• • Use of fertility enhancing medications